| 0.9 % w/v Sodium Chloride Injection BP PA0179/002/013 |
Sodium chloride |
B. Braun Medical Limited |
Marketed |
| 0.9% Sodium Chloride Intravenous Infusion Solution PA1968/018/001 |
Sodium chloride |
Laboratoire Aguettant |
Not marketed |
| 1% w/v Lidocaine Hydrochloride Injection BP PA0736/044/001 |
Lidocaine Hydrochloride Monohydrate |
B. Braun Melsungen AG |
Marketed |
| 10 mg/ml Solution for infusion EU/1/19/1383/001-002 |
Lacosamide |
UCB Pharma S.A. |
— |
| 100 units/mL Tempo Pen solution for injection in pre-filled pen EU/1/20/1422/016-017 |
Insulin lispro |
Eli Lilly Nederland B.V. |
— |
| 2% w/v Lidocaine Hydrochloride Injection BP PA0736/044/002 |
Lidocaine Hydrochloride Monohydrate |
B. Braun Melsungen AG |
Marketed |
| 200 units/mL KwikPen solution for injection in pre-filled pen EU/1/20/1422/013-015 |
Insulin lispro |
Eli Lilly Nederland B.V. |
— |
| 5% Glucose Intravenous Infusion Solution PA1968/019/001 |
Glucose |
Laboratoire Aguettant |
Not marketed |
| 8.4% w/v Sodium Bicarbonate Intravenous Infusion BP PA0179/006/001 |
Sodium bicarbonate |
B. Braun Medical Limited |
Marketed |
| A.Vogel Uva-ursi & Echinacea Cystitis oral drops TR2309/021/001 |
|
A.Vogel Ireland Limited |
Marketed |
| Abacavir/Lamivudine Mylan 600 mg/300 mg film-coated tablets PA0577/193/001 |
Abacavir, Lamivudine |
McDermott Laboratories Ltd., T/A Gerard Laboratories |
Not marketed |
| Abacavir/Lamivudine Viatris 600 mg/300 mg Film-coated Tablets PA23266/056/001 |
Abacavir sulfate, Lamivudine |
Viatris Limited |
Marketed |
| ABASAGLAR 100 units/mL solution for injection in a cartridge EU/1/14/944/001-004 |
Insulin glargine |
Eli Lilly Nederland B.V. |
— |
| ABASAGLAR 100 units/mL solution for injection in a pre-filled pen EU/1/14/944/005-008 |
Insulin glargine |
Eli Lilly Nederland B.V. |
— |
| Abecma 260 - 500 x 106 cells dispersion for infusion EU/1/21/1539/001 |
Idecabtagene Vicleucel |
Bristol-Myers Squibb Pharmaceuticals uc |
— |
| Abendur 2.5 mg tablets PA23163/004/001 |
Bendroflumethiazide |
Ascot Laboratories (Ireland) Limited |
— |
| Abendur 5 mg tablets PA23163/004/002 |
Bendroflumethiazide |
Ascot Laboratories (Ireland) Limited |
— |
| Abevmy 25 mg/mL concentrate for solution for infusion EU/1/20/1515/001-005 |
Bevacizumab |
Biosimilar Collaborations Ireland Limited |
— |
| Abidec Multivitamin Oral Drops Solution PA1186/001/001 |
Ergocalciferol, Thiamine hydrochloride, Riboflavin sodium phosphate, Pyridoxine hydrochloride, Nicotinamide |
Chefaro Ireland DAC |
Marketed |
| Abilify 1 mg/mL oral solution EU/1/04/276/033-035 |
Aripiprazole |
Otsuka Pharmaceutical Netherlands B.V. |
— |
| Abilify 10 mg orodispersible tablets EU/1/04/276/024-026 |
Aripiprazole |
Otsuka Pharmaceutical Netherlands B.V. |
— |
| Abilify 10 mg tablets EU/1/04/276/006-010 |
Aripiprazole |
Otsuka Pharmaceutical Netherlands B.V. |
— |
| Abilify 15 mg orodispersible tablets EU/1/04/276/027-029 |
Aripiprazole |
Otsuka Pharmaceutical Netherlands B.V. |
— |
| Abilify 15 mg tablets EU/1/04/276/011-015 |
Aripiprazole |
Otsuka Pharmaceutical Netherlands B.V. |
— |
| Abilify 30 mg orodispersible tablets EU/1/04/276/030-032 |
Aripiprazole |
Otsuka Pharmaceutical Netherlands B.V. |
— |
| Abilify 30 mg tablets EU/1/04/276/016-020 |
Aripiprazole |
Otsuka Pharmaceutical Netherlands B.V. |
— |
| Abilify 5 mg tablets EU/1/04/276/001-005 |
Aripiprazole |
Otsuka Pharmaceutical Netherlands B.V. |
— |
| Abilify 7.5 mg/mL solution for injection EU/1/04/276/036 |
Aripiprazole |
Otsuka Pharmaceutical Netherlands B.V. |
— |
| Abilify Maintena 300 mg powder and solvent for prolonged-release suspension for injection EU/1/13/882/001,003 |
Aripiprazole |
Otsuka Pharmaceutical Netherlands B.V. |
— |
| Abilify Maintena 400 mg powder and solvent for prolonged-release suspension for injection EU/1/13/882/002,004 |
Aripiprazole |
Otsuka Pharmaceutical Netherlands B.V. |
— |
| Abilify Maintena 720 mg prolonged-release suspension for injection in pre-filled syringe EU/1/13/882/009 |
Aripiprazole Monohydrate |
Otsuka Pharmaceutical Netherlands B.V. |
— |
| Abilify Maintena 960 mg prolonged-release suspension for injection in pre-filled syringe EU/1/13/882/010 |
Aripiprazole Monohydrate |
Otsuka Pharmaceutical Netherlands B.V. |
— |
| Abiraterone 500 mg film-coated tablets PA0711/304/002 |
Abiraterone acetate |
Rowex Limited, |
Not marketed |
| Abiraterone Accord 250 mg tablets EU/1/20/1512/001 |
Abiraterone acetate |
Accord Healthcare S.L.U. |
— |
| Abiraterone Accord 500 mg film-coated tablets EU/1/20/1512/002-003 |
Abiraterone acetate |
Accord Healthcare S.L.U. |
— |
| Abiraterone Aristo 250 mg tablets PA1983/008/001 |
Abiraterone acetate |
Aristo Pharma GmbH |
Not marketed |
| Abiraterone Aristo 500 mg film-coated tablets PA1983/008/002 |
Abiraterone acetate |
Aristo Pharma GmbH |
Marketed |
| Abiraterone AshCure 250 mg film-coated tablets PA25251/001/001 |
Abiraterone acetate |
AshCure Pharma B.V. |
Not marketed |
| Abiraterone AshCure 500 mg film-coated tablets PA25251/001/002 |
Abiraterone acetate |
AshCure Pharma B.V. |
Not marketed |
| Abiraterone Clonmel 500 mg film-coated tablets PA0126/336/001 |
Abiraterone acetate |
Clonmel Healthcare Ltd |
Marketed |
| Abiraterone Krka 500 mg film-coated tablets EU/1/21/1553/001-003 |
Abiraterone acetate |
KRKA, d.d., Novo mesto |
— |
| Abiraterone Mylan 1000 mg film-coated tablets EU/1/21/1571/009-012 |
Abiraterone acetate |
Mylan Pharmaceuticals Limited |
— |
| Abiraterone Mylan 500 mg film-coated tablets EU/1/21/1571/001-008 |
Abiraterone acetate |
Mylan Pharmaceuticals Limited |
— |
| Abiraterone Rowa 500 mg Film-coated tablets PA0074/092/001 |
Abiraterone acetate |
Rowa Pharmaceuticals Limited, |
Marketed |
| Abiraterone Teva 500 mg film-coated tablets PA1986/103/001 |
Abiraterone acetate |
Teva B.V. |
Marketed |
| Abraxane 5 mg/ml powder for dispersion for infusion EU/1/07/428/001 |
Paclitaxel |
Bristol-Myers Squibb Pharma EEIG |
— |
| Abrysvo powder and solvent for solution for injection Respiratory syncytial virus vaccine (bivalent, recombinant) EU/1/23/1752/001-006 |
Respiratory syncytial virus, subgroup A, stabilized prefusion F protein 847A, Respiratory syncytial virus, subgroup B, stabilized prefusion F protein 847B |
Pfizer Europe MA EEIG |
— |
| Abseamed 1 000 IU/0.5 mL solution for injection in a pre-filled syringe EU/1/07/412/1-2 |
Recombinant human erythropoietin alfa |
Medice Arzneimittel Putter GmbH & Co. K.G |
— |
| Abseamed 10 000 IU/1 mL solution for injection in a pre-filled syringe EU/1/07/412/15-16 |
Recombinant human erythropoietin alfa |
Medice Arzneimittel Putter GmbH & Co. K.G |
— |
| Abseamed 2 000 IU/1 mL solution for injection in a pre-filled syringe EU/1/07/412/3-4 |
Recombinant human erythropoietin alfa |
Medice Arzneimittel Putter GmbH & Co. K.G |
— |